What is the difference between obinutuzumab and rituximab?

Obinutuzumab is a type II antibody, unlike rituximab, which is a type I antibody. These classifications are based on the way the antibodies bind to CD20.

Is obinutuzumab immunotherapy or chemotherapy?

Obinutuzumab is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug.

Is bendamustine rituximab chemotherapy?

Bendamustine (Bendeka®) + Rituximab is a Chemotherapy Regimen for Lymphoma, B-cell.

How long does it take to recover from bendamustine?

Tiredness and weakness You might feel very tired during your treatment. It might take 6 months to a year for your energy levels to get back to normal after the treatment ends. A low red blood cell count will also make you feel tired.

Does obinutuzumab cause hair loss?

You could lose all your hair. This includes your eyelashes, eyebrows, underarm, leg and sometimes pubic hair. Your hair will usually grow back once treatment has finished but it is likely to be softer. It may grow back a different colour or be curlier than before.

Is obinutuzumab considered immunotherapy?

Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

How will I feel after obinutuzumab?

This medicine may cause an infusion reaction within a few hours after you receive it. Check with your doctor right away if you have chest pain, itching, hives, a rash, flushing of the face, dizziness, fainting, lightheadedness, trouble breathing, swelling of the face, tongue, and throat, a fever, or chills.

Do you lose your hair with obinutuzumab?

What are the long term effects of bendamustine?

This medicine may increase your risk of developing a serious and rare brain infection called progressive multifocal leukoencephalopathy (PML). Check with your doctor if you have weakness on one side of the body, clumsiness, blurred vision, changes in thinking, memory problems, confusion, or personality changes.

What type of chemotherapy is bendamustine?

Bendamustine is a type of chemotherapy drug called an alkylating agent.

How do you feel after bendamustine?

What to Expect After Bendamustine Treatment (Side Effects)

1. nausea.
2. vomiting.
3. diarrhea.
4. heartburn.
5. constipation.
6. stomach pain or swelling.
7. sores or white patches in the mouth.
8. dry mouth.

Does obinutuzumab cause weight gain?

Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.

What are the side effects of obinutuzumab?

Side Effects

• Back pain.
• black, tarry stools.
• blood in the urine or stools.
• chest tightness.
• flushing.
• hoarseness.
• pinpoint red spots on the skin.
• trouble breathing.

Does bendamustine cause weight gain?

What are the side effects of Obinutuzumab?

Will I lose my hair on bendamustine?

In a safety evaluation from a clinical study for CLL, hair loss occurred in 1 of the 153 patients treated with bendamustine hydrochloride compared to 0 (zero) of the 143 patients treated with chlorambucil. In an NHL study, hair loss occurred in 3 of the 100 patients treated with bendamustine hydrochloride.

What are the long term side effects of bendamustine?

Does obinutuzumab improve outcomes in follicular lymphoma?

Rituximab-based immunochemotherapy has improved outcomes in patients with follicular lymphoma. Obinutuzumab is a glycoengineered type II anti-CD20 monoclonal antibody. We compared rituximab-based chemotherapy with obinutuzumab-based chemotherapy in patients with previously untreated advanced-stage follicular lymphoma.

What is the dose of obinutuzumab plus bendamustine?

Obinutuzumab plus bendamustine dosing was obinutuzumab 1000 mg (days 1, 8, and 15, cycle 1; day 1, cycles 2-6) plus bendamustine 90 mg/m (2) per day (days 1 and 2, cycles 1-6), and bendamustine monotherapy dosing was 120 mg/m (2) per day (days 1 and 2, all cycles).

Does bendamustine cause hypogammaglobulinaemia?

After 360 days, he was noted to have persistent pancytopenia and hypogammaglobulinaemia, which was attributed to bendamustine therapy. However, it was normal prior to the initiation of bendamustine therapy. After 390 days from the initial diagnosis, he received first dose of COVID-19-Vaccine-Pfizer-BioNTech [Pfizer-BioNTech COVID-19 vaccine].

Can obinutuzumab cause thrombocytopenia?

Severe and life threatening thrombocytopenia, including acute thrombocytopenia (occurring within 24 hours after the infusion) has been observed during treatment with obinutuzumab. Fatal haemorrhagic events have also been reported in cycle one of treatment.